Skip to main content
Top
Published in: BMC Nephrology 1/2018

Open Access 01-12-2018 | Case report

Monoclonal light chain crystalline podocytopathy and tubulopathy associated with monoclonal gammopathy of renal significance: a case report and literature review

Authors: Xiao-juan Yu, Xu-jie Zhou, Su-xia Wang, Fu-de Zhou, Ming-hui Zhao

Published in: BMC Nephrology | Issue 1/2018

Login to get access

Abstract

Background

Monoclonal gammopathy of renal significance (MGRS) is a recently defined group of renal diseases caused by monoclonal immunoglobulin secreted by nonmalignant proliferative B cell or plasma cell. Monoclonal immunoglobulin can form different types of structures deposited in renal tissue, including fibrils, granules, microtubules, crystals and casts, and has mostly been reported in multiple myeloma patients. Here we report a rare case with κ light chain crystals in both podocytes and tubular epithelial cells associated with MGRS, which adds more information to the spectrum of MGRS-related renal diseases.

Case presentation

A 53-year old woman presented with albumin–predominant moderate proteinuria and renal failure. She had monoclonal IgGκ in the serum and monoclonal IgGκ plus free κ in the urine. Multiple myeloma and lymphoproliferative disorders were excluded. Renal biopsy confirmed κ-restricted crystal-storing renal disease involving the podocytes and proximal tubular epithelial cells. The patient was treated with bortezomib followed by lenalidomide-based chemotherapy, and renal function was stable after 1 year of follow-up.

Conclusions

This is a rare case of combined crystalline podocytopathy and tubulopathy associated with MGRS, in which diagnosis was dependent on electron and immuno-electron microscopy.
Literature
1.
go back to reference Bridoux F, et al. Diagnosis of monoclonal gammopathy of renal significance. Kidney Int. 2015;87(4):698–711.CrossRef Bridoux F, et al. Diagnosis of monoclonal gammopathy of renal significance. Kidney Int. 2015;87(4):698–711.CrossRef
2.
go back to reference Leung N, et al. Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant. Blood. 2012;120(22):4292–5.CrossRef Leung N, et al. Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant. Blood. 2012;120(22):4292–5.CrossRef
3.
go back to reference Carstens PH, Woo D. Crystalline glomerular inclusions in multiple myeloma. Am J Kidney Dis. 1989;14(1):56–60.CrossRef Carstens PH, Woo D. Crystalline glomerular inclusions in multiple myeloma. Am J Kidney Dis. 1989;14(1):56–60.CrossRef
4.
go back to reference Yamamoto T, et al. Crystal-storing histiocytosis and crystalline tissue deposition in multiple myeloma. Arch Pathol Lab Med. 1991;115(4):351–4.PubMed Yamamoto T, et al. Crystal-storing histiocytosis and crystalline tissue deposition in multiple myeloma. Arch Pathol Lab Med. 1991;115(4):351–4.PubMed
5.
go back to reference Kowalewska J, Tomford RC, Alpers CE. Crystals in podocytes: an unusual manifestation of systemic disease. Am J Kidney Dis. 2003;42(3):605–11.CrossRef Kowalewska J, Tomford RC, Alpers CE. Crystals in podocytes: an unusual manifestation of systemic disease. Am J Kidney Dis. 2003;42(3):605–11.CrossRef
6.
go back to reference Papla B, et al. Generalized crystal-storing histiocytosis as a presentation of multiple myeloma: a case with a possible pro-aggregation defect in the immunoglobulin heavy chain. Virchows Arch. 2004;445(1):83–9.PubMed Papla B, et al. Generalized crystal-storing histiocytosis as a presentation of multiple myeloma: a case with a possible pro-aggregation defect in the immunoglobulin heavy chain. Virchows Arch. 2004;445(1):83–9.PubMed
7.
go back to reference Tomioka M, et al. Widespread crystalline inclusions affecting podocytes, tubular cells and interstitial histiocytes in the myeloma kidney. Clin Nephrol. 2004;62(3):229–33.CrossRef Tomioka M, et al. Widespread crystalline inclusions affecting podocytes, tubular cells and interstitial histiocytes in the myeloma kidney. Clin Nephrol. 2004;62(3):229–33.CrossRef
8.
go back to reference Keller LS, et al. Crystalloid deposits in the kidney. Nephrology (Carlton). 2005;10(1):81–3.CrossRef Keller LS, et al. Crystalloid deposits in the kidney. Nephrology (Carlton). 2005;10(1):81–3.CrossRef
9.
go back to reference Akilesh S, Alem A, Nicosia RF. Combined crystalline podocytopathy and tubulopathy associated with multiple myeloma. Hum Pathol. 2014;45(4):875–9.CrossRef Akilesh S, Alem A, Nicosia RF. Combined crystalline podocytopathy and tubulopathy associated with multiple myeloma. Hum Pathol. 2014;45(4):875–9.CrossRef
10.
go back to reference Jeon YL, et al. Crystalloid podocytopathy with focal segmental glomerulosclerosis in PCM: a case report. Diagn Pathol. 2015;10:213.CrossRef Jeon YL, et al. Crystalloid podocytopathy with focal segmental glomerulosclerosis in PCM: a case report. Diagn Pathol. 2015;10:213.CrossRef
11.
go back to reference Lee EJ, et al. Crystalline podocytopathy and tubulopathy without overt glomerular proteinuria in a patient with multiple myeloma. Kidney Res Clin Pract. 2016;35(4):259–62.CrossRef Lee EJ, et al. Crystalline podocytopathy and tubulopathy without overt glomerular proteinuria in a patient with multiple myeloma. Kidney Res Clin Pract. 2016;35(4):259–62.CrossRef
12.
go back to reference Khalighi MA, et al. Light chain Podocytopathy mimicking recurrent focal segmental glomerulosclerosis. Am J Transplant. 2017;17(3):824–9.CrossRef Khalighi MA, et al. Light chain Podocytopathy mimicking recurrent focal segmental glomerulosclerosis. Am J Transplant. 2017;17(3):824–9.CrossRef
13.
go back to reference Nasr SH, et al. Multiple myeloma, nephrotic syndrome and crystalloid inclusions in podocytes. Kidney Int. 2006;69(3):616–20.CrossRef Nasr SH, et al. Multiple myeloma, nephrotic syndrome and crystalloid inclusions in podocytes. Kidney Int. 2006;69(3):616–20.CrossRef
14.
go back to reference Matsuyama N, et al. Crystalline inclusions in the glomerular podocytes in a patient with benign monoclonal gammopathy and focal segmental glomerulosclerosis. Am J Kidney Dis. 1994;23(6):859–65.CrossRef Matsuyama N, et al. Crystalline inclusions in the glomerular podocytes in a patient with benign monoclonal gammopathy and focal segmental glomerulosclerosis. Am J Kidney Dis. 1994;23(6):859–65.CrossRef
15.
go back to reference Elliott MR, et al. Plasma cell dyscrasia causing light chain tubulopathy without Fanconi syndrome. Am J Kidney Dis. 2010;55(6):1136–41.CrossRef Elliott MR, et al. Plasma cell dyscrasia causing light chain tubulopathy without Fanconi syndrome. Am J Kidney Dis. 2010;55(6):1136–41.CrossRef
16.
go back to reference Jokiranta TS, et al. Nephritogenic lambda light chain dimer: a unique human miniautoantibody against complement factor H. J Immunol. 1999;163(8):4590–6.PubMed Jokiranta TS, et al. Nephritogenic lambda light chain dimer: a unique human miniautoantibody against complement factor H. J Immunol. 1999;163(8):4590–6.PubMed
17.
go back to reference Leboulleux M, et al. Protease resistance and binding of Ig light chains in myeloma-associated tubulopathies. Kidney Int. 1995;48(1):72–9.CrossRef Leboulleux M, et al. Protease resistance and binding of Ig light chains in myeloma-associated tubulopathies. Kidney Int. 1995;48(1):72–9.CrossRef
18.
go back to reference Deret S, et al. Kappa light chain-associated Fanconi's syndrome: molecular analysis of monoclonal immunoglobulin light chains from patients with and without intracellular crystals. Protein Eng. 1999;12(4):363–9.CrossRef Deret S, et al. Kappa light chain-associated Fanconi's syndrome: molecular analysis of monoclonal immunoglobulin light chains from patients with and without intracellular crystals. Protein Eng. 1999;12(4):363–9.CrossRef
19.
go back to reference Messiaen T, et al. Adult Fanconi syndrome secondary to light chain gammopathy. Clinicopathologic heterogeneity and unusual features in 11 patients. Medicine (Baltimore). 2000;79(3):135–54.CrossRef Messiaen T, et al. Adult Fanconi syndrome secondary to light chain gammopathy. Clinicopathologic heterogeneity and unusual features in 11 patients. Medicine (Baltimore). 2000;79(3):135–54.CrossRef
20.
go back to reference Thorner PS, Bedard YC, Fernandes BJ. Lambda-light-chain nephropathy with Fanconi's syndrome. Arch Pathol Lab Med. 1983;107(12):654–7.PubMed Thorner PS, Bedard YC, Fernandes BJ. Lambda-light-chain nephropathy with Fanconi's syndrome. Arch Pathol Lab Med. 1983;107(12):654–7.PubMed
21.
go back to reference Sethi S, et al. Crystal-storing histiocytosis involving the kidney in a low-grade B-cell lymphoproliferative disorder. Am J Kidney Dis. 2002;39(1):183–8.CrossRef Sethi S, et al. Crystal-storing histiocytosis involving the kidney in a low-grade B-cell lymphoproliferative disorder. Am J Kidney Dis. 2002;39(1):183–8.CrossRef
Metadata
Title
Monoclonal light chain crystalline podocytopathy and tubulopathy associated with monoclonal gammopathy of renal significance: a case report and literature review
Authors
Xiao-juan Yu
Xu-jie Zhou
Su-xia Wang
Fu-de Zhou
Ming-hui Zhao
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2018
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-018-1108-x

Other articles of this Issue 1/2018

BMC Nephrology 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.